Paul Blanchfield, Lantheus' President, is confident in Morgan's ability to guide the company's commercial activities and generate value. Morgan is excited about her new role and the opportunity to advance Lantheus' diverse portfolio.
Gapping up In reaction to earnings/guidance: •$Aehr Test Systems(AEHR.US)$+11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems) •$Tilray Brands(TLRY.US)$+5.1% Other news: •$Payoneer Global(PAYO.US)$+8.1% (to join SaP SmallCap 600) •$Atlas(ATCO.US)$+6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
There are few best-performing stocks in 2022 the companies trade on major US stocks, such as several oil and gas stocks benefiting from surging energy prices and health care stocks as well. The S&P 500 remains down more than 10% this year, but some of the top-performing stocks have bucked the bearish trend. Some others stock might still in bearish trend based on current economy situation, most companies still in a bad conditions except for those top-performing stocks, as below: -$Target Hospitality(TH.US)$ ...
Upgrades •$信諾(CI.US)$: Cowen Upgrades to Outperform from Market Perform - PT $329 (from $242) •$DLocal(DLO.US)$: New Street Research Upgrades to Buy from Neutral - PT $38 •$固特異輪胎橡膠(GT.US)$: CFRA Upgrades to Buy from Hold - PT $20 (from $24) •$Match group(MTCH.US)$: Wells Fargo Upgrades to Overweight from Equal Weight - PT $115 (from $140) •$普雷斯蒂奇(PBH.US)$: Oppenheimer Upgrades to Outperform from Perform - P...
Lantheus股票討論區
4 PDUFA decisions this week!
$百濟神州(BGNE.US)$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$施貴寶(BMY.US)$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$萬達生物製藥(VNDA.US)$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia(EYEN.US)$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...
專欄US Top Gap Ups and Downs on 8/3: REGN, PYPL, QCOM, MCK and More
Gap Ups
1. $高樂氏(CLX.US)$ - up 4.6%
2. $高知特(CTSH.US)$ - up 4.1%
3. $Informatica(INFA.US)$ - up 2.8%
4. $BOSS直聘(BZ.US)$ - up 2.7%
5. $Sunrun(RUN.US)$ - up 2.6%
6. $再生元製藥公司(REGN.US)$ - up 1.9%
7. $麥克森(MCK.US)$ - up 1.9%
8. $寇蒂斯萊特(CW.US)$ - up 1.7%
9. $MercadoLibre(MELI.US)$ - up 1.5...
2023Q1營收增長44%,營業利潤和淨利潤反而陷入虧損,主要是成本增速遠高於營收增速,也就是毛利率大幅下滑導致的。
目前市盈率達到了232,沒有甚麼吸引力。
專欄US Top Gap Ups and Downs on 5/4: FHN, WAL, SHOP, RACE and More
Gap Ups
1. $Shopify(SHOP.US)$ - up 12.4%
2. $鮑爾包裝(BALL.US)$ - up 5.6%
3. $SolarEdge Technologies(SEDG.US)$ - up 4.2%
4. $Datadog(DDOG.US)$ - up 4.1%
5. $Fleetcor Technologies(FLT.US)$ - up 3.5%
6. $高知特(CTSH.US)$ - up 3.3%
7. $AngloGold Ashanti(AU.US)$ - up 3.0%
8. $Lantheus(LNTH.US)$ - up 2.9...
專欄US Top Gap Ups and Downs on 3/8: XP, SNAP, ETSY, LI and More
Gap Ups
1. $XP Inc(XP.US)$ - up 2.0%
2. $Cosan(CSAN.US)$ - up 1.1%
3. $Sabesp(SBS.US)$ - up 1.1%
4. $以色列化學(ICL.US)$ - up 0.8%
5. $Lantheus(LNTH.US)$ - up 0.5%
Gap Downs
1. $Snap Inc(SNAP.US)$ - down 1.7%
2. $Etsy Inc(ETSY.US)$ - down 1.3%
3. $理想汽車(LI.US)$ - down 1.2%
4. $Pinterest(PINS.US)$ - down 1....
專欄Today's Pre-Market Stock Movers: AMD, NVDA, INTC, TSM and More
In reaction to earnings/guidance:
• $Aehr Test Systems(AEHR.US)$ +11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems)
• $Tilray Brands(TLRY.US)$ +5.1%
Other news:
• $Payoneer Global(PAYO.US)$ +8.1% (to join SaP SmallCap 600)
• $Atlas(ATCO.US)$ +6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
Market
- $Target Hospitality(TH.US)$
...
專欄Top upgrades and downgrades on 5/9
• $信諾(CI.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $329 (from $242)
• $DLocal(DLO.US)$ : New Street Research Upgrades to Buy from Neutral - PT $38
• $固特異輪胎橡膠(GT.US)$ : CFRA Upgrades to Buy from Hold - PT $20 (from $24)
• $Match group(MTCH.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $115 (from $140)
• $普雷斯蒂奇(PBH.US)$ : Oppenheimer Upgrades to Outperform from Perform - P...
暫無評論